eXmoor pharma unveils new manufacturing facility in Bristol
EXmoor pharma has opened the doors to its new cell and gene therapy centre GMP facility, based in Bristol, UK.
Source: biopharma-reporter.com
Page 36 - Bio Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bio Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bio Developments Today - Breaking & Trending Today
Alvotech's AVT05 emerges as leading contender in rheumatoid arthritis market
The patent for Janssen’s second-generation, tumour necrosis factor-alpha (TNF)-a inhibitor Simponi (golimumab), is scheduled to expire in 2024 and in 2025 in the US and EU, respectively.
Source: biopharma-reporter.com
Terumo BTC and BioCentriq to generate public CAR-T cell data
Terumo Blood and Cell Technologies, a medical tech company, and BioCentriq, a cell therapy contract development and manufacturing organization (CDMO), are working together to demonstrate the capabilities of Terumo’s automated cell and gene therapy platforms to accelerate CAR-T cell development.
Source: biopharma-reporter.com
OrganaBio unveils new division for vaccine and cell and gene therapy clinical trials
OrganaBio, a contract technology development and manufacturing organization (CTDMO) specializing in solutions for cell and immunotherapy development, has launched a new division.
Source: biopharma-reporter.com
Could umbilical cords hold the key to treating diabetes?
NextCell is a biotech company developing a novel treatment for type 1 diabetes, comprised of stem cells found in umbilical cords.
Source: biopharma-reporter.com